Cargando…
Prevalence of Cardiometabolic Disease Risk Factors in People With HIV Initiating Antiretroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda
BACKGROUND: Cardiometabolic diseases are a leading cause of HIV-related morbidity and mortality, yet routine screening is not undertaken in high-burden countries. We aimed to assess the prevalence and risk factors of the metabolic syndrome (MetS) and its components in adult Ugandan people with HIV (...
Autores principales: | Amutuhaire, Willington, Mulindwa, Frank, Castelnuovo, Barbara, Brusselaers, Nele, Schwarz, Jean-Marc, Edrisa, Mutebi, Dujanga, Simon, Salata, Robert A, Yendewa, George A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284103/ https://www.ncbi.nlm.nih.gov/pubmed/37351455 http://dx.doi.org/10.1093/ofid/ofad241 |
Ejemplares similares
-
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
por: Mulindwa, Frank, et al.
Publicado: (2023) -
Implementation of longitudinal insulin kinetic studies in busy field settings in Uganda: experience from the “glucose metabolism changes in Ugandan HIV patients on dolutegravir based anti-retroviral therapy” (GLUMED study)
por: Mulindwa, Frank, et al.
Publicado: (2023) -
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023) -
Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
por: Mulindwa, Frank, et al.
Publicado: (2023) -
Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks
por: Mulindwa, Frank, et al.
Publicado: (2023)